BOSTON (AP) — BOSTON (AP) — Aktis Oncology Inc. (AKTS) on Monday reported a loss of $18.3 million in its first quarter.
The Boston-based company said it had a loss of 38 cents per share.
The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 31 cents per share.
The clinical-stage oncology company posted revenue of $3.2 million in the period, topping Street forecasts. Four analysts surveyed by Zacks expected $2.9 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AKTS at https://www.zacks.com/ap/AKTS
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
